Alison Bauerlein's most recent trade in Sight Sciences Inc was a trade of 13,066 Common Stock done at an average price of $3.5 . Disclosure was reported to the exchange on May 19, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.48 per share. | 19 May 2025 | 13,066 | 636,728 | - | 3.5 | 45,430 | Common Stock |
Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 02 Apr 2025 | 19,397 | 649,794 | - | 2.3 | 44,788 | Common Stock |
Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 286,738 | 669,191 | - | 0 | Common Stock | |
Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.52 per share. | 03 Jan 2025 | 10,102 | 382,453 | - | 3.5 | 35,579 | Common Stock |
Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.08 per share. | 01 Oct 2024 | 10,130 | 392,555 | - | 6.1 | 61,590 | Common Stock |
Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.21 per share. | 02 Jul 2024 | 10,497 | 402,685 | - | 6.2 | 65,207 | Common Stock |
Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.42 per share. | 17 May 2024 | 13,066 | 413,182 | - | 5.4 | 70,870 | Common Stock |
Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 03 Apr 2024 | 10,123 | 426,248 | - | 5.1 | 51,415 | Common Stock |
Sight Sciences Inc | Bauerlein Alison | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 315,421 | 436,371 | - | 0 | Common Stock | |
Sight Sciences Inc | Alison Bauerlein | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 103,000 | 0 | - | 0 | Common Stock | |
Sight Sciences Inc | Alison Bauerlein | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 71,800 | 71,800 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 546 | 4,915 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 546 | 34,392 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.66 per share. | 01 Dec 2021 | 490 | 33,902 (0%) | 0% | 29.7 | 14,533 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.57 per share. | 01 Sep 2021 | 616 | 3,691 (0%) | 0% | 60.6 | 37,311 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 546 | 4,307 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 546 | 5,461 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 253 | 0 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 253 | 3,761 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 80.01 per share. | 30 Jul 2021 | 8,235 | 3,779 (0%) | 0% | 80.0 | 658,923 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.54 per share. | 30 Jul 2021 | 8,235 | 12,014 (0%) | 0% | 38.5 | 317,377 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2021 | 8,235 | 30,292 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 80.33 per share. | 30 Jul 2021 | 1,397 | 3,779 (0%) | 0% | 80.3 | 112,216 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jul 2021 | 1,397 | 28,895 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.54 per share. | 30 Jul 2021 | 1,397 | 5,176 (0%) | 0% | 38.5 | 53,840 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 75.02 per share. | 27 Jul 2021 | 9,632 | 3,779 (0%) | 0% | 75.0 | 722,565 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.54 per share. | 27 Jul 2021 | 9,632 | 13,411 (0%) | 0% | 38.5 | 371,217 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2021 | 9,632 | 38,527 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.34 per share. | 01 Jun 2021 | 614 | 3,508 (0%) | 0% | 60.3 | 37,049 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 546 | 6,007 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 546 | 4,122 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 252 | 3,576 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 252 | 253 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.54 per share. | 13 Apr 2021 | 1,641 | 4,965 (0%) | 0% | 38.5 | 63,244 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 60.14 per share. | 13 Apr 2021 | 1,641 | 3,324 (0%) | 0% | 60.1 | 98,684 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 1,641 | 48,159 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 13 Apr 2021 | 1,200 | 3,324 (0%) | 0% | 60.0 | 72,002 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 1,200 | 49,800 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.54 per share. | 13 Apr 2021 | 1,200 | 4,524 (0%) | 0% | 38.5 | 46,248 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 18,098 | 0 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.62 per share. | 15 Mar 2021 | 18,098 | 21,422 (0%) | 0% | 16.6 | 300,789 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 52.01 per share. | 15 Mar 2021 | 11,586 | 9,836 (0%) | 0% | 52.0 | 602,619 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 52.61 per share. | 15 Mar 2021 | 6,512 | 3,324 (0%) | 0% | 52.6 | 342,598 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 12,231 | 12,231 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,184 | 4,752 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,184 | 6,553 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.14 per share. | 01 Mar 2021 | 1,428 | 3,324 (0%) | 0% | 53.1 | 75,884 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 253 | 2,568 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 253 | 505 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 18,098 | 18,098 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.62 per share. | 16 Feb 2021 | 18,098 | 20,413 (0%) | 0% | 16.6 | 300,789 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 53.83 per share. | 16 Feb 2021 | 17,398 | 4,447 (0%) | 0% | 53.8 | 936,496 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 55.19 per share. | 16 Feb 2021 | 700 | 2,315 (0%) | 0% | 55.2 | 38,630 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 09 Feb 2021 | 8,973 | 2,315 (0%) | 0% | 55.1 | 494,038 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2021 | 8,973 | 0 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.81 per share. | 09 Feb 2021 | 8,973 | 11,288 (0%) | 0% | 0.8 | 7,268 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2021 | 8,973 | 8,973 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 50.04 per share. | 26 Jan 2021 | 8,973 | 2,315 (0%) | 0% | 50.0 | 448,967 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.81 per share. | 26 Jan 2021 | 8,973 | 11,288 (0%) | 0% | 0.8 | 7,268 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2021 | 18,098 | 36,196 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.62 per share. | 15 Jan 2021 | 18,098 | 20,413 (0%) | 0% | 16.6 | 300,789 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 44.28 per share. | 15 Jan 2021 | 15,966 | 4,447 (0%) | 0% | 44.3 | 706,912 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 44.83 per share. | 15 Jan 2021 | 2,132 | 2,315 (0%) | 0% | 44.8 | 95,584 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.62 per share. | 15 Dec 2020 | 8,702 | 11,017 (0%) | 0% | 16.6 | 144,627 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 8,702 | 0 | - | - | Stock Option (Right to Buy) | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 39.44 per share. | 15 Dec 2020 | 4,449 | 6,568 (0%) | 0% | 39.4 | 175,464 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 41.33 per share. | 15 Dec 2020 | 2,349 | 2,315 (0%) | 0% | 41.3 | 97,084 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Sale of securities on an exchange or to another person at price $ 40.42 per share. | 15 Dec 2020 | 1,904 | 4,664 (0%) | 0% | 40.4 | 76,960 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Grant, award, or other acquisition of securities at price $ 35.28 per share. | 01 Dec 2020 | 253 | 32,815 (0%) | 0% | 35.3 | 8,926 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 253 | 758 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.28 per share. | 01 Dec 2020 | 126 | 32,689 (0%) | 0% | 35.3 | 4,445 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.28 per share. | 01 Dec 2020 | 117 | 32,470 (0%) | 0% | 35.3 | 4,128 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.28 per share. | 01 Dec 2020 | 102 | 32,587 (0%) | 0% | 35.3 | 3,599 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2020 | 252 | 32,906 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2020 | 252 | 1,011 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.94 per share. | 01 Sep 2020 | 125 | 32,781 (0%) | 0% | 28.9 | 3,618 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.94 per share. | 01 Sep 2020 | 117 | 32,562 (0%) | 0% | 28.9 | 3,386 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.94 per share. | 01 Sep 2020 | 102 | 32,679 (0%) | 0% | 28.9 | 2,952 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 253 | 32,998 (0%) | 0% | 0 | Common Stock | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 253 | 1,263 | - | - | Restricted Stock Unit | |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.55 per share. | 01 Jun 2020 | 126 | 32,872 (0%) | 0% | 38.5 | 4,857 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.55 per share. | 01 Jun 2020 | 116 | 32,654 (0%) | 0% | 38.6 | 4,472 | Common Stock |
Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.55 per share. | 01 Jun 2020 | 102 | 32,770 (0%) | 0% | 38.5 | 3,932 | Common Stock |